BR0206165A - Derivado de fosfonato de nucleosìdeo acìclico, processo para preparar o composto, composto de fosfonato, e, uso do derivado de fosfonato de nucleosìdeo acìclico - Google Patents
Derivado de fosfonato de nucleosìdeo acìclico, processo para preparar o composto, composto de fosfonato, e, uso do derivado de fosfonato de nucleosìdeo acìclicoInfo
- Publication number
- BR0206165A BR0206165A BR0206165-1A BR0206165A BR0206165A BR 0206165 A BR0206165 A BR 0206165A BR 0206165 A BR0206165 A BR 0206165A BR 0206165 A BR0206165 A BR 0206165A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- acyclic nucleoside
- phosphonate
- derivative
- phosphonate derivative
- Prior art date
Links
- VWFCHDSQECPREK-LURJTMIESA-N Cidofovir Chemical class NC=1C=CN(C[C@@H](CO)OCP(O)(O)=O)C(=O)N=1 VWFCHDSQECPREK-LURJTMIESA-N 0.000 title abstract 4
- -1 phosphonate compound Chemical class 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 241000700721 Hepatitis B virus Species 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 239000002777 nucleoside Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20010003087 | 2001-01-19 | ||
| PCT/KR2002/000086 WO2002057288A1 (en) | 2001-01-19 | 2002-01-18 | Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0206165A true BR0206165A (pt) | 2004-02-03 |
Family
ID=36241797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0206165-1A BR0206165A (pt) | 2001-01-19 | 2002-01-18 | Derivado de fosfonato de nucleosìdeo acìclico, processo para preparar o composto, composto de fosfonato, e, uso do derivado de fosfonato de nucleosìdeo acìclico |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US7157448B2 (enExample) |
| EP (1) | EP1358198B1 (enExample) |
| JP (1) | JP3959348B2 (enExample) |
| KR (1) | KR100441638B1 (enExample) |
| CN (1) | CN100347185C (enExample) |
| AR (1) | AR035933A1 (enExample) |
| AT (1) | ATE478887T1 (enExample) |
| AU (1) | AU2002230230B2 (enExample) |
| BR (1) | BR0206165A (enExample) |
| CA (1) | CA2433591C (enExample) |
| DE (1) | DE60237429D1 (enExample) |
| DK (1) | DK1358198T3 (enExample) |
| EG (1) | EG24382A (enExample) |
| ES (1) | ES2350197T3 (enExample) |
| MX (1) | MXPA03006001A (enExample) |
| MY (1) | MY141789A (enExample) |
| NZ (1) | NZ526632A (enExample) |
| PL (1) | PL212730B1 (enExample) |
| PT (1) | PT1358198E (enExample) |
| RU (1) | RU2266294C2 (enExample) |
| WO (1) | WO2002057288A1 (enExample) |
| ZA (1) | ZA200304181B (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY141789A (en) | 2001-01-19 | 2010-06-30 | Lg Chem Investment Ltd | Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same. |
| WO2002069900A2 (en) * | 2001-03-01 | 2002-09-12 | Conforma Therapeutics Corp. | Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors |
| WO2003037860A2 (en) | 2001-10-30 | 2003-05-08 | Conforma Therapeutics Corporation | Purine analogs having hsp90-inhibiting activity |
| AU2003263644A1 (en) * | 2002-09-26 | 2004-04-19 | Lg Life Sciences Ltd. | (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof |
| US7138401B2 (en) | 2003-09-18 | 2006-11-21 | Conforma Therapeutics Corporation | 2-aminopurine analogs having HSP90-inhibiting activity |
| KR20050062940A (ko) * | 2003-12-19 | 2005-06-28 | 주식회사 엘지생명과학 | 디이소프로필((1-((2-아미노-6-할로-9ｈ-퓨린-9-일)메틸)사이클로프로필)옥시)-메틸포스포네이트의 새로운 제조방법 |
| KR20050062944A (ko) * | 2003-12-19 | 2005-06-28 | 주식회사 엘지생명과학 | 디이소프로필((1-((2-아미노-6-클로로-9ｈ-퓨린-9-일)메틸)사이클로프로필)옥시)-메틸포스포네이트의 새로운 제조방법 |
| US20060052346A1 (en) * | 2004-02-17 | 2006-03-09 | Averett Devron R | Nucleoside phosphonate derivatives useful in the treatment of HIV infections |
| KR101033290B1 (ko) * | 2004-07-02 | 2011-05-09 | 주식회사 엘지생명과학 | 다이아이소프로필((1-(하이드록시메틸)-사이클로프로필)옥시)메틸포스포네이트의 새로운 제조 방법 |
| EP1831235B1 (en) | 2004-12-16 | 2013-02-20 | The Regents of The University of California | Lung-targeted drugs |
| CA2602257A1 (en) * | 2005-03-30 | 2006-10-05 | Conforma Therapeutics Corporation | Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors |
| US7674018B2 (en) * | 2006-02-27 | 2010-03-09 | Illumination Management Solutions Inc. | LED device for wide beam generation |
| US8434912B2 (en) * | 2006-02-27 | 2013-05-07 | Illumination Management Solutions, Inc. | LED device for wide beam generation |
| GB0623493D0 (en) * | 2006-11-24 | 2007-01-03 | Univ Cardiff | Chemical compounds |
| TWI384986B (zh) * | 2007-01-17 | 2013-02-11 | Lg Life Sciences Ltd | 抗病毒劑之順丁烯二酸單鹽以及含有該單鹽之醫藥組成物 |
| EA019919B1 (ru) | 2007-04-13 | 2014-07-30 | Саузерн Рисерч Инститьют | Способ подавления роста или метастазирования ангиогенез-зависимой опухоли |
| WO2008144672A1 (en) * | 2007-05-21 | 2008-11-27 | Illumination Management Solutions, Inc. | An improved led device for wide beam generation and method of making the same |
| EP2326870B1 (en) * | 2008-08-14 | 2017-01-25 | Cooper Technologies Company | Led devices for offset wide beam generation |
| WO2010065663A2 (en) * | 2008-12-03 | 2010-06-10 | Illumination Management Solutions, Inc. | An led replacement lamp and a method of replacing preexisting luminaires with led lighting assemblies |
| CN102093422B (zh) | 2009-12-10 | 2015-02-25 | 中国人民解放军军事医学科学院毒物药物研究所 | 无环核苷膦酸酯衍生物及其医药用途 |
| CN102286026B (zh) * | 2010-06-18 | 2014-07-02 | 中国人民解放军军事医学科学院毒物药物研究所 | 无环核苷酸类似物的盐及其晶型和药物组合物 |
| FI2648701T3 (fi) | 2010-12-10 | 2023-06-12 | Sigmapharm Laboratories Llc | Hyvin stabiileja adefovirdipivoksiilin koostumuksia |
| CN107312039B (zh) | 2012-08-30 | 2019-06-25 | 江苏豪森药业集团有限公司 | 一种替诺福韦前药的制备方法 |
| EP3401320B1 (en) | 2013-03-15 | 2020-05-13 | The Regents of the University of California | Acyclic nucleoside phosphonate diesters for use in treating human papilloma virus, cervical intraepithelial neoplasia, anal intraepithelial neoplasia, or vulvar intraepithelial neoplasia |
| CN104119385B (zh) * | 2014-07-24 | 2017-04-05 | 廖国超 | 核苷类似物的磷酸酯前药及其应用 |
| RS63250B1 (sr) | 2014-09-15 | 2022-06-30 | Univ California | Nukleotidni analozi |
| CN106432330B (zh) * | 2015-08-11 | 2019-02-01 | 天津科伦药物研究有限公司 | Lb80380药物的中间体化合物及其制备方法和用途 |
| WO2017048956A1 (en) | 2015-09-15 | 2017-03-23 | The Regents Of The University Of California | Nucleotide analogs |
| CN106977548A (zh) * | 2016-01-19 | 2017-07-25 | 四川海思科制药有限公司 | 倍司福韦复合物及其制备方法和用途 |
| CN107849074A (zh) * | 2016-01-19 | 2018-03-27 | 四川海思科制药有限公司 | 一种核苷类似物的烷氧烷基酯前药及其应用 |
| KR102623581B1 (ko) * | 2016-07-18 | 2024-01-11 | 일동제약(주) | 항바이러스성 약물의 오로트산염, 이의 제조 방법 및 상기 염을 포함하는 약제학적 조성물 |
| CN108276443A (zh) * | 2017-01-06 | 2018-07-13 | 米文君 | 一种新的化合物及其用途 |
| KR102096144B1 (ko) * | 2017-07-03 | 2020-04-01 | 주식회사 엘지화학 | 포스포네이트 뉴클레오사이드계 b형 간염 치료제 합성용 중간체 화합물의 연속식 제조방법 |
| CN108997429B (zh) * | 2018-07-27 | 2020-10-30 | 广州粤美医药科技有限公司 | 一种制备贝西福韦的方法 |
| CN113735863A (zh) * | 2021-09-29 | 2021-12-03 | 武汉九州钰民医药科技有限公司 | Wee1抑制剂adavosertib的制备工艺 |
| CN113880883A (zh) * | 2021-11-11 | 2022-01-04 | 奥锐特药业股份有限公司 | 核苷类磷酸酯前药的制备方法 |
| CN114560463B (zh) * | 2022-03-23 | 2023-10-20 | 福州大学 | 一种核壳结构的氮掺杂碳壳包裹碳化钼核微米球材料的制备方法 |
| CA3262284A1 (en) | 2022-07-21 | 2024-01-25 | Antiva Biosciences, Inc. | Pharmaceutical compositions and forms for the treatment of human papillomavirus (HPV) infection and HPV-induced neoplasm |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1494321A (en) * | 1974-08-08 | 1977-12-07 | Ici Ltd | Prostanoic acid derivatives |
| US5688778A (en) | 1989-05-15 | 1997-11-18 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Nucleoside analogs |
| GB8922076D0 (en) | 1989-09-28 | 1989-11-15 | Beecham Group Plc | Novel process |
| US5177104A (en) | 1990-04-03 | 1993-01-05 | E. R. Squibb & Sons, Inc. | 6-α-hydroxy derivatives of mevinic acids |
| US5302585A (en) * | 1990-04-20 | 1994-04-12 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents |
| DK0465297T3 (da) * | 1990-07-04 | 1996-02-19 | Merrell Pharma Inc | 9-Purinylphosphonsyre-derivater |
| ES2118069T3 (es) | 1990-09-14 | 1998-09-16 | Acad Of Science Czech Republic | Profarmacos de fosfonatos. |
| DK0502690T3 (da) * | 1991-03-05 | 2000-05-22 | Ajinomoto Kk | Cyclopropanderivat |
| US5817647A (en) | 1993-04-01 | 1998-10-06 | Merrell Pharmaceuticals Inc. | Unsaturated acetylene phosphonate derivatives of purines |
| EP0632048B1 (en) | 1993-06-29 | 2001-03-21 | Mitsubishi Chemical Corporation | Phosphonate-nucleotide ester derivatives |
| WO1995007919A1 (en) | 1993-09-17 | 1995-03-23 | Gilead Sciences, Inc. | Method for dosing therapeutic compounds |
| WO1995022330A1 (en) | 1994-02-17 | 1995-08-24 | Commonwealth Scientific And Industrial Research Organisation | Antiviral agents |
| IT1270008B (it) | 1994-09-23 | 1997-04-16 | Ist Superiore Sanita | Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids |
| US5977061A (en) | 1995-04-21 | 1999-11-02 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | N6 - substituted nucleotide analagues and their use |
| US5874577A (en) * | 1996-04-03 | 1999-02-23 | Medichem Research, Inc. | Method for the preparing 9-12-(Diethoxyphosphonomethoxy)ethyl!adenine and analogues thereof |
| US5877166A (en) | 1996-04-29 | 1999-03-02 | Sri International | Enantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agents |
| US5922695A (en) * | 1996-07-26 | 1999-07-13 | Gilead Sciences, Inc. | Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability |
| US5935946A (en) | 1997-07-25 | 1999-08-10 | Gilead Sciences, Inc. | Nucleotide analog composition and synthesis method |
| NZ502837A (en) | 1997-08-15 | 2001-01-26 | Medivir Ab | Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase of hepatitis B virus (HBV) |
| MY141789A (en) | 2001-01-19 | 2010-06-30 | Lg Chem Investment Ltd | Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same. |
| DE60329375D1 (en) * | 2002-03-15 | 2009-11-05 | Univ Wayne State | Neue 2-amino-9-((2-hydroxymethyl)cyclopropylidenmethyl)-purine als antivirale mittel |
| AU2003263644A1 (en) * | 2002-09-26 | 2004-04-19 | Lg Life Sciences Ltd. | (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof |
-
2002
- 2002-01-16 MY MYPI20020143A patent/MY141789A/en unknown
- 2002-01-18 DK DK02711484.2T patent/DK1358198T3/da active
- 2002-01-18 RU RU2003125372/04A patent/RU2266294C2/ru not_active IP Right Cessation
- 2002-01-18 DE DE60237429T patent/DE60237429D1/de not_active Expired - Lifetime
- 2002-01-18 BR BR0206165-1A patent/BR0206165A/pt not_active IP Right Cessation
- 2002-01-18 AU AU2002230230A patent/AU2002230230B2/en not_active Ceased
- 2002-01-18 WO PCT/KR2002/000086 patent/WO2002057288A1/en not_active Ceased
- 2002-01-18 PT PT02711484T patent/PT1358198E/pt unknown
- 2002-01-18 AT AT02711484T patent/ATE478887T1/de active
- 2002-01-18 CA CA002433591A patent/CA2433591C/en not_active Expired - Fee Related
- 2002-01-18 PL PL373670A patent/PL212730B1/pl not_active IP Right Cessation
- 2002-01-18 EP EP02711484A patent/EP1358198B1/en not_active Expired - Lifetime
- 2002-01-18 NZ NZ526632A patent/NZ526632A/en not_active IP Right Cessation
- 2002-01-18 KR KR10-2002-0003051A patent/KR100441638B1/ko not_active Expired - Fee Related
- 2002-01-18 CN CNB028037774A patent/CN100347185C/zh not_active Expired - Lifetime
- 2002-01-18 MX MXPA03006001A patent/MXPA03006001A/es active IP Right Grant
- 2002-01-18 JP JP2002557964A patent/JP3959348B2/ja not_active Expired - Fee Related
- 2002-01-18 US US10/450,780 patent/US7157448B2/en not_active Expired - Fee Related
- 2002-01-18 ES ES02711484T patent/ES2350197T3/es not_active Expired - Lifetime
- 2002-01-19 EG EG20020063A patent/EG24382A/xx active
- 2002-01-21 AR ARP020100197A patent/AR035933A1/es active IP Right Grant
-
2003
- 2003-05-29 ZA ZA200304181A patent/ZA200304181B/en unknown
-
2006
- 2006-06-20 US US11/455,679 patent/US7605147B2/en not_active Expired - Fee Related
-
2009
- 2009-09-09 US US12/585,229 patent/US7723319B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0206165A (pt) | Derivado de fosfonato de nucleosìdeo acìclico, processo para preparar o composto, composto de fosfonato, e, uso do derivado de fosfonato de nucleosìdeo acìclico | |
| UY26758A1 (es) | Agentes antivirales de imidazopiridina e imidazopirimidina | |
| BRPI0612104A8 (pt) | composto, mistura diastereomérica, composição farmacêutica, e, método para tratar infecções por hepatite c em um paciente e para tratar infecções por hcv em um paciente | |
| UY28084A1 (es) | Derivados antivirales de nucleosidos | |
| BR9916772A (pt) | Quinolinacarboxamidas como agentes antivirais | |
| BR0309712A (pt) | Processo para a preparação de carbonitrilas 7-substituìda-3-quinolina e 3-quinol-4-ona | |
| ECSP055801A (es) | Compuestos benzofuránicos, composiciones y métodos para el tratamiento y profilaxis de infecciones virales de hepatitis c y enfermedades asociadas | |
| CL2008003431A1 (es) | Compuestos derivados de nucleosidos 2',4' sustituidos; proceso de preparacion de dichos compuestos; composicion farmaceutica que los comprende; su metodo de preparacion; y su uso para el tratamiento y/o la prevencion de cualquier condicion resultante de una infeccion por vhb, vhc o vih. | |
| ECSP11005768A (es) | Derivados de azol-pirimidina condensados | |
| NZ597544A (en) | Modified 4'-nucleosides as antiviral agents | |
| MXPA03002022A (es) | Conjugados de inhibidor de neuraminidas multivalentes. | |
| BR0213040A (pt) | Composto, processo para preparar um composto, e, método de tratar doenças | |
| BR0114316A (pt) | Processo para a preparação de formulações em pó | |
| WO2002011764A3 (en) | PHARMACEUTICAL COMPOSITIONS | |
| BR0114896A (pt) | Preparação contendo nateglinida, e, método para produzir a mesma | |
| BR0212069A (pt) | Agentes antidiabéticos orais | |
| MXPA06000418A (es) | Derivados de ariltiourea sustituida utiles como inhibidores de duplicacion viral. | |
| BR0111729A (pt) | 1-aril-4-oxo-1,4-dihidro-3-quinolinacarboxamidas como agentes antivirais | |
| BR0211691A (pt) | Processo para a prepara de tolterodina | |
| PH12022552516A1 (en) | Pharmaceutical composition for preventing or treating epidemic rna viral infectious disease | |
| BR0011902A (pt) | Compostos derivados de ciclopentano substituìdo, respectivos processos de preparação e formas cristalinas | |
| ATE491441T1 (de) | Antivirale zusammensetzung mit p-menthan-3,8-diol | |
| BR0314695A (pt) | Composto, processo para preparar um composto, processo para preparar um estereoisÈmero de um composto, composição para o tratamento de doenças virais, e, composição para o tratamento da hepatite b | |
| BR9916807A (pt) | Antagonistas de 5ht1 para terapia antidepressiva | |
| BR9810804A (pt) | Processo para a preparação de 2' -fluor-5-metil-beta-l-arabinofuranosiluridina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |